The past, present, and future of contact lenses

Article

During the Contact Lens Global Forum, a partnership between Vision Expo East and the British Contact Lens Association, Mile Brujic, OD, Nick Rumney, MScO, FCO, FAAO, and Lyndon Jones, PhD, FCOptom, DipCLP, DipOrth, explored where contact lenses have been and where they’re going.

New York City-During the Contact Lens Global Forum, a partnership between Vision Expo East and the British Contact Lens Association, Mile Brujic, OD, Nick Rumney, MScO, FCO, FAAO, and Lyndon Jones, PhD, FCOptom, DipCLP, DipOrth, explored where contact lenses have been and where they’re going.

While the contact lenses started out made of glass in the 1800s, says Dr. Brujic, lens technology evolved greatly over the last half of the 20th century. Soft plastics were used beginning in 1958, and by the 1970s, there was the introduction of Bausch + Lomb’s Soflens and gas permeable lenses. By 1987, Johnson & Johnson had introduced the disposable lens, and less than a decade later, the company introduced the daily disposable.

Today, the contact lens market has evolved to have options for a variety of needs, yet dropouts remain high. Dr. Rumney says that eyecare practitioners (ECPs) must be enthusiastic and open to experiences with all of the available contact lens options.

Dr. Jones gave a glimpse into the not-so-distant future with a look at emerging contact lens technology, citing devices like the Sensimed Triggerfish, which can monitor glaucoma. The device, though not yet approved in the United States, according to its Web site, uses a contact lens to monitor the curvature of the eye over a period of 24 hours. The lens transmits the measurements to a receiver worn around the neck.

Other emerging contact lens technology includes lenses that can monitor glucose levels, simplifying testing for the hundreds of millions of diabetics worldwide. Lenses may one day be used to monitor cancer, as lacryglobin is elevated in human tears in patients with breast, colon, lung, prostate, and ovarian cancers, and a lens could be developed to sense the biomarker. Contact lenses are also being investigated as a means to administer drugs.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Shelby Brogdon, OD, details opportunities for practices to answer the patient's concerns from the chair before they hit the internet for their contact lens needs.
Christi Closson, OD, FAAO, shares her excitement for the new Acuvue Oasys MAX 1-Day multifocal for astigmatism
Karen R. Hoffman, OD, shares how customizable scleral lenses can transform vision for patients with complex corneas, achieving 20/20 outcomes and enhanced comfort.
When Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, began fitting scleral lenses 20 years ago, there was limited knowledge about conjunctival characteristics, scleral shape, and lens behavior.
Ioussifova details what sets Johnson & Johnson's new lens apart from the rest, which was launched at the American Optometric Association's Optometry's Meeting 2025.
Karen R. Hoffman, OD, speaks on her AOA 2025 poster, which details a case series on fitting patients with irregular cornea and astigmatism with Zenlens (Bausch + Lomb)
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
Rhue and Canto-Sims talk the value of contact lens patients, financial insights, and key benefits of implementing a contact lens management system.
Drs Brianna Rhue and Diana Canto-Sims discuss the benefits of implementing a contact lens management system that can help improve lens sales at your practice.
© 2025 MJH Life Sciences

All rights reserved.